日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial

回复:优化慢性淋巴细胞白血病临床试验中的对照组:BRUIN-CLL-321试验

Sharman, Jeff P; Liu, Bin; Wang, Denise Y; Leow, Ching Ching; Barr, Paul M

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma

纳武利尤单抗联合维布妥昔单抗治疗复发/难治性弥漫性大B细胞淋巴瘤

Johnson, Nathalie A; Zinzani, Pier Luigi; Domingo-Domenech, Eva; Brody, Joshua; Kline, Justin; Shah, Bijal Dinesh; Mehta, Amitkumar Nitinkumar; Ghesquieres, Herve; Savage, Kerry J; Barr, Paul M; Santoro, Armando; Ferrari, Silvia; Cunningham, David; Collins, Graham P; Fanale, Michelle; Krajewski, Jennifer; Akyol, Alev; Crowe, Russell; Wen, Rachael; Kuruvilla, John

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

在共价布鲁顿酪氨酸激酶抑制剂预处理的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤中,Pirtobrutinib 与 Idelalisib/Rituximab 或 Bendamustine/Rituximab 的 III 期试验 (BRUIN CLL-321)

Sharman, Jeff P; Munir, Talha; Grosicki, Sebastian; Roeker, Lindsey E; Burke, John M; Chen, Christine I; Grzasko, Norbert; Follows, George; Mátrai, Zoltán; Sanna, Alessandro; Qiu, Lugui; Feng, Ru; Hua, Vu Minh; Jurczak, Wojciech; Ritgen, Matthias; Yi, Shuhua; Bosch, Francesc; Coombs, Catherine C; Bao, Katherine; Patel, Vishalkumar; Liu, Bin; Compte, Livia; Guntur, Ananya; Wang, Denise Y; Hill, Marisa; Leow, Ching Ching; Ghia, Paolo; Barr, Paul M

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

RESONATE-2 研究的最终分析:对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤一线伊布替尼治疗进行长达 10 年的随访。

Burger, Jan A; Barr, Paul M; Robak, Tadeusz; Owen, Carolyn; Tedeschi, Alessandra; Sarma, Anita; Patten, Piers E M; Grosicki, Sebastian; McCarthy, Helen; Offner, Fritz; Szafer-Glusman, Edith; Zhou, Cathy; Szoke, Anita; Neumayr, Lynne; Dean, James P; Ghia, Paolo; Kipps, Thomas J

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

功能基因组学和肿瘤微环境分析揭示套细胞淋巴瘤的预后生物学亚型

Sharma, Sunandini; Ali, Roshia; Bouska, Alyssa; Jochum, Dylan; Kesireddy, Meghana; Mahov, Simeon; Lownik, Joseph; Zhang, Weiwei; Lone, Waseem; Soma, Mahfuza Afroz; Gamboa, Alicia; Devarakonda, Vaishnavi; El-Gamal, Dalia; Fariha, Atqiya; Mansoor, Adnan; Stewart, Douglas; Martin, Peter; Link, Brian K; Advani, Ranjana H; Barr, Paul M; Goy, Andre H; Mehta, Amitkumar; Kamdar, Manali; Stephens, Deborah M; Bachanova, Veronika; Smith, Lynette; Morin, Ryan; Pararajalingam, Prasath; Lunning, Matthew A; Fu, Kai; Weisenburger, Dennis; Chan, Wing C; Khoury, Joseph; Greiner, Timothy C; Vose, Julie M; Merchant, Akil; Bi, Chengfeng; Iqbal, Javeed

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

维奈托克联合疗法在布鲁顿酪氨酸激酶抑制剂治疗慢性淋巴细胞白血病后的疗效:一项国际真实世界研究

Ghosh, Nilanjan; Eyre, Toby A; Brown, Jennifer R; Lamanna, Nicole; Manzoor, Beenish S; Coombs, Catherine C; Tuncer, Hande H; Ujjani, Chaitra; Leslie, Lori A; Roeker, Lindsey E; Davids, Matthew S; Rhodes, Joanna M; Skarbnik, Alan P; Sinai, Wendy; Fleury, Isabelle; Hill, Brian T; Martinez-Calle, Nicolas; Barr, Paul M; Jawaid, Dureshahwar; Emechebe, Nnadozie; Pearson, Laurie; Lansigan, Frederick; Choi, Yun; Jensen, Christopher E; Fakhri, Bita; Stephens, Deborah M; Marx, Steven E; Schuster, Stephen J; Coyle, Michael; Pivneva, Irina; Watson, Talissa; Guerin, Annie; Shadman, Mazyar

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

E1912 研究中,接受伊布替尼治疗的 CLL 患者中,IGHV 突变状态与耐受性和长期疾病控制之间的关系

Shanafelt, Tait D; Wang, Xin Victoria; Hanson, Curtis A; Paietta, Elisabeth; O'Brien, Susan; Barrientos, Jacqueline; Jelinek, Diane F; Braggio, Esteban; Leis, Jose F; Zhang, Cong Christine; Barr, Paul M; Cashen, Amanda F; Mato, Anthony R; Singh, Avina K; Mullane, Michael P; Little, Richard F; Erba, Harry; Stone, Richard M; Litzow, Mark; Tallman, Martin; Kay, Neil E

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

A041202 研究的后续结果显示,伊布替尼治疗方案对老年慢性淋巴细胞白血病 (CLL) 患者持续有效。

Woyach, Jennifer A; Perez Burbano, Gabriela; Ruppert, Amy S; Miller, Cecelia; Heerema, Nyla A; Zhao, Weiqiang; Wall, Anna; Ding, Wei; Bartlett, Nancy L; Brander, Danielle M; Barr, Paul M; Rogers, Kerry A; Parikh, Sameer A; Stephens, Deborah M; Brown, Jennifer R; Lozanski, Gerard; Blachly, James; Nattam, Sreenivasa; Larson, Richard A; Erba, Harry; Litzow, Mark; Luger, Selina; Owen, Carolyn; Kuzma, Charles; Abramson, Jeremy S; Little, Richard F; Dinner, Shira; Stone, Richard M; Uy, Geoffrey; Stock, Wendy; Mandrekar, Sumithra J; Byrd, John C

First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis

一线伊布替尼治疗慢性淋巴细胞白血病患者的总生存率与年龄匹配的一般人群相似:一项汇总的事后分析

Ghia, Paolo; Owen, Carolyn; Allan, John N; Barrientos, Jacqueline C; Barr, Paul M; Shi, Chunxue; Szoke, Anita; Abbazio, Christopher; Krigsfeld, Gabriel S; Burger, Jan A

Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial

维生素D治疗低肿瘤负荷惰性非霍奇金淋巴瘤患者(接受利妥昔单抗治疗)的效果:一项随机、3期临床试验

Friedberg, Jonathan W; Brady, Michael T; Strawderman, Myla; Kahl, Brad S; Lossos, Izidore S; Cohen, Jonathon B; Reagan, Patrick M; Casulo, Carla; Averill, Barbara L; Baran, Andrea; Sutamtewagul, Grerk; Barr, Paul M; Leonard, John P; Ashton, John M; Strang, John G; Vega, Francisco; Peterson, Derick R; Nastoupil, Loretta J